Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07388355

A Usability Study of a Multi-channel ECG Monitoring Device

This study it to evaluate the usability of the WearLinq eWave patch in a general adult population.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

ABio Clinical Research Partners

New London, North Carolina, 28127, United States

Location status: Recruiting

Location contact

Andrea Brown, MS

CONTACT

[email protected]

408-881-2611

About this study

Once eligibility is determined, participants will receive and apply the WearLinq patch for 7 consecutive days (or until an endpoint is met). A subset of subjects will be asked to participate in an Extended Use Cohort (30 days).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult >18 years old and able to consent
  • Capable of using a smartphone app
  • Willing to shave patch area if needed

Exclusion criteria

  • Planning to undergo an MRI during the study period
  • Known allergic reaction to adhesives or hydrogels or with family history of adhesive skin allergies, or any other dermatological conditional that could confound placement or results
  • Presence of pacemaker, ICD or other implanted electronic devices
  • Open wounds, lesions or infected or inflamed areas of skin at the placement site (left-center of chest/sternum)
  • Pregnant or intending to become pregnant during the course of the study

Treatment and study plan

eWave Patch

Device

This device is a wearable multi-channel ECG monitoring device for continuous cardiac rhythm tracking.

Primary outcomes

  1. Wear Duration

    Time frame: 7 Days

    Days of use until one of the following is reached: patch no longer adheres, signal loss, voluntary removal, or 7 days is achieved

  2. Adverse Events

    Time frame: 7 Days

    Incidences of self-reported adverse events for the duration of the study

Study contacts

Contact information is provided by the study sponsor or research team.

Andrea Brown, MS

CONTACT

[email protected]

408-881-2611

Chris Daniel

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Wearlinq

Industry

Collaborators

  • ABio Clinical Research Partners

Registry information

Official study title

WearLinq eWave Patch Study

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Feb 5, 2026
Registry last updated
Jul 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.